Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- family history
- history of asbestos exposure
- age between 60 and 85 years
- shortness of breath
- diminished breath sounds
- dullness to percussion
Otros factores de diagnóstico
- male sex
- chest pain
- cough
- constitutional symptoms
- abdominal distention and/or pain
Factores de riesgo
- asbestos exposure
- age 60 to 85 years
- asbestos exposure during home maintenance and renovation
- male sex
- radiation exposure
- genetic predisposition
- simian virus 40 (SV-40)
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- CXR
- CT chest and upper abdomen (with contrast)
Pruebas diagnósticas que deben considerarse
- thoracentesis
- PET/CT scan
- pleural biopsy
- video-assisted thoracoscopic surgery (VATS)
- immunohistochemistry
- germline testing
- chest MRI
- cervical mediastinoscopy
- pulmonary function tests
- CBC
- basic metabolic panel
Pruebas emergentes
- diagnostic biomarkers
Algoritmo de tratamiento
resectable disease
unresectable or recurrent disease
Colaboradores
Autores
Hedy Kindler, MD
Professor of Medicine
Associate Dean for Clinical Science Research, Human Subjects
The University of Chicago, Biological Sciences Division
Section of Hematology/Oncology
Chicago
Divulgaciones
HK declares she has no competing interests.
Agradecimientos
Dr Hedy Kindler would like to gratefully acknowledge Dr Idrees Mian, Dr Jaydira del Rivero, Dr Anish Thomas, Mrs Mary Hesdorffer, Dr Robert Taub, and Dr Chris R. Kelsey, the previous contributors to this topic.
Divulgaciones
IM, JdR, AT, MH, RT, and CRK declare that they have no competing interests.
Revisores por pares
Marc de Perrot, MD, MSc
Associate Professor of Surgery
University of Toronto
Division of Thoracic Surgery
Toronto General Hospital
Ontario
Canada
Divulgaciones
MdP is an author of a reference cited in this topic.
Tom Treasure, MD, MS FRCS, FRCP
Professor of Cardiothoracic Surgery (Honorary)
Clinical Operational Research Unit
Department of Mathematics
University College London
London
UK
Disclosures
TT is an author of a reference cited in this topic.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: mesothelioma: pleural [internet publication].Full text
Woolhouse I, Bishop L, Darlison L, et al. British Thoracic Society guideline for the investigation and management of malignant pleural mesothelioma. Thorax. 2018 Mar;73(suppl 1):i1-30.Full text Abstract
Popat S, Baas P, Faivre-Finn C, et al. Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022 Feb;33(2):129-42.Full text Abstract
Kindler HL, Ismaila N, Bazhenova L, et al. Treatment of pleural mesothelioma: ASCO guideline update. J Clin Oncol. 2025 Mar 10;43(8):1006-38.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Benign reactive mesothelial hyperplasia
- Benign asbestos-related pleural reactions
- Non-small cell lung cancer
More DifferentialsGuidelines
- Mesothelioma: pleural
- Suspected cancer: recognition and referral
More GuidelinesVideos
Pleural aspiration animated demonstration
More videos
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer